COMP <GO>
ACHC vs CDNA // FREE CASH FLOW YIELD
Acadia Healthcare Company Inc. (NASDAQ) VS. CareDx Inc. (NASDAQ) • 15-METRIC TALLY: ACHC 1
— CDNA 9
▲ FREE CASH FLOW YIELD LEADER: CDNA
LAST: $29.96 (+1.70%) • MKT CAP: $2.79B
fcf-yield
-16.04%
LAST: $87.41 (+22.22%) • MKT CAP: $4.59B
fcf-yield
0.67%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACHC VS. CDNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACHC | CDNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -24.80% | -8.20% | -16.60 | CDNA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -16.04% | 0.67% | -16.71 | CDNA | /fcf-yield <GO> |
| Operating Margin | -40.60% | -8.10% | -32.50 | CDNA | /operating-margins <GO> |
| Net Profit Margin | -33.30% | -5.60% | -27.70 | CDNA | /net-margins <GO> |
| Revenue Growth (YoY) | 5.00% | 13.80% | -8.80 | CDNA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 19.22 | -18.77 | CDNA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | CDNA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.9 | 67.4 | -16.50 | CDNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 1.06 | +0.01 | ACHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 21.0x | 0.00 | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.79B | $4.59B | -$1.80B | CDNA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACHC REV | CDNA REV | ACHC GROSS % | CDNA GROSS % | ACHC FCF | CDNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.31B | $379.8M | — | — | -$439.9M | $24.9M |
| FY 2024 | $3.15B | $333.8M | — | — | -$560.7M | $23.0M |
| FY 2023 | $2.93B | $280.3M | — | — | $330.5M | -$31.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACHC // BETA 1.07
CDNA // BETA 1.06